...
首页> 外文期刊>Prescrire international >Normalisation of school behaviour with methylphenidate
【24h】

Normalisation of school behaviour with methylphenidate

机译:用甲基酚的学校行为正常化

获取原文
获取原文并翻译 | 示例
           

摘要

In children, the diagnosis of attention deficit disorder, with or without hyperactivity, is made on the basis of several non-specific symptoms, including difficulty concentrating in school, motor agitation, and impulsivity; the boundaries are blurred. In 2016, methylphenidate, an amphetamine-like psychostimulant, was being used in these situations in France in about 60 000 children and adolescents aged less than 20 years, despite having at best modest symptomatic efficacy, while its cardiovascular and neuropsychological adverse effects are sometimes serious. It should only be offered as a last resort, when non-drug interventions have failed (1). In spite of these reservations, the diagnosis of attention deficit hyperactivity disorder (ADHD) in school-age children, and their treatment with methylphenidate, has sharply increased in many countries (2-4).
机译:在儿童中,在几种非特异性症状的基础上,在几种非特异性症状的基础上诊断注意力缺陷症,有或没有多动,包括集中在学校,运动搅拌和冲动的困难; 界限被模糊。 2016年,尽管具有最佳适度的对症疗效,但在法国的这些情况下,在法国的这些情况下,在法国的这些情况下使用了甲基苯胺,但其心血管和神经心理学不良影响有时是严重的 。 当非药物干预失败时,它应该只为最后的手段提供(1)。 尽管有这些保留,但在许多国家(2-4),学龄儿童中注意力缺陷多动障碍(ADHD)及其用甲基酚的治疗诊断。

著录项

  • 来源
    《Prescrire international》 |2019年第204期|共1页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号